Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oroboros Instruments develops and distributes gold-standard high-resolution respirometry devices used globally to study mitochondrial function and cellular bioenergetics. Their flagship product line—the Oxygraph-O2k series—enables precise analysis of oxygen consumption rates and related parameters in isolated mitochondria, cells or tissues. These instruments support basic research as well as translational studies across a wide range of disease areas including metabolic disorders and neurodegeneration. The company has an extensive global user base (>1570 instruments in >50 countries), supports a large network of reference labs (>760), organizes international workshops on HRR techniques (~170 held), and its technology has been cited in thousands of scientific publications (>4800).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oroboros Instruments.